Trending storyDeveloping
Zolbetuximab, Durvalumab, and FLOT Combination Neoadjuvant Chemotherapy for CLDN18.2-Positive Gastric Cancer or Gastroesophageal Junction Adenocarcinoma
1 report1 sourceupdated 2 hours ago
Start here
No synthesis yet — start with the coverage timeline below.
Coverage timeline
Follow the coverage to see the different angles.
Heat trend for this story
Not enough continuous observation yet to draw a trend.